Back to top

MediWound assumed with an Outperform at Oppenheimer

Oppenheimer assumed coverage of MediWound (MDWD) with an Outperform rating with a price target of $34, down from $36. The firm notes the company’s ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

MediWound Ltd. (MDWD)